SGLT2 Inhibitor-Associated Ketoacidosis vs Type 1 Diabetes-Associated Ketoacidosis

被引：4

作者：

Umapathysivam, Mahesh M. ^{[1
,2
,3
,4
,5
,6
]}

Morgan, Bethany ^{[3
,4
]}

Inglis, Joshua M. ^{[3
,5
]}

Meyer, Emily ^{[3
,4
,5
]}

Liew, Danny ^{[5
]}

Thiruvenkatarajan, Venkatesan ^{[7
]}

Jesudason, David ^{[3
,4
,5
,8
]}

机构：

[1] Royal Adelaide Hosp, Endocrine & Metab Unit, Port Rd, Adelaide, SA 5000, Australia

[2] Flinders Med Ctr, Southern Adelaide Diabet & Endocrine Serv, Adelaide, SA, Australia

[3] Queen Elizabeth Hosp, Endocrine Dept, Woodville, SA, Australia

[4] Royal Adelaide Hosp, Endocrine Dept, Adelaide, SA, Australia

[5] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia

[6] Univ Adelaide, Ctr Res Excellence Translating Nutr Sci Good Hlth, Adelaide, SA, Australia

[7] Queen Elizabeth Hosp, Anaesthet Dept, Woodville, SA, Australia

[8] Basil Hetzel Inst, Woodville, SA, Australia

来源：

JAMA NETWORK OPEN | 2024年 / 7卷 / 03期

关键词：

D O I：

10.1001/jamanetworkopen.2024.2744

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This cohort study examines the natural history and response to treatment of sodium glucose cotransporter 2 (SGLT2) inhibitor-associated ketoacidosis compared with that of type 1 diabetes-associated ketoacidosis.

引用

页数：4

共 50 条

[21] SGLT2 inhibitors and ketoacidosis in inpatients with diabetes
Maharajan, V.
Cherian, T.
Jones, R.
Hards, K.
Anguelova, L.
Lumb, A.
Rea, R.
Owen, K.
Tan, G.
DIABETIC MEDICINE, 2022, 39
[22] Diabetic ketoacidosis in a patient with type 2 diabetes precipitated by infection, steroids and SGLT2 inhibitor
Aung, Ei Thuzar
Koshy, Rithika Mary
Jacob, Koshy
PRACTICAL DIABETES, 2019, 36 (02) : 69 - +
[23] A case series of diabetic ketoacidosis associated with SGLT2 inhibitors
Zac-Varghese, Sagen
Mathew, Sunitha
Go, Daniel
Winocour, Peter
PRACTICAL DIABETES, 2023, 40 (03) : 21 - +
[24] FEARS study: SGLT2 inhibitors associated with ketoacidosis risk
Hamann, Andreas
DIABETOLOGIE UND STOFFWECHSEL, 2018, 13 (02) : 138 - +
[25] SGLT-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A Case Report and a Literature Review
Mahfooz, Rabia Salman
Khan, Muhammad Khuzzaim
Al Hennawi, Hussam
Khedr, Anwar
CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
[26] Euglycemic Ketoacidosis as a Complication of SGLT2 Inhibitor Therapy
Palmer, Biff F.
Clegg, Deborah J.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (08): : 1284 - 1291
[27] Acid-base changes during diabetic ketoacidosis in type 1 diabetes with/without SGLT2 inhibitor
Mursic, I.
Svehlikova, E.
Regittnig, W.
Urschitz, M.
Wolf, M.
Brunner, M.
Augustin, T.
Magnes, C.
Eberl, A.
Heise, T.
Klein, O.
Sourij, H.
Pieber, T.
DIABETOLOGIA, 2020, 63 (SUPPL 1) : S272 - S273
[28] Ketoacidosis with SGLT2 Inhibitors
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1471): : 94 - 94
[29] SGLT2 inhibitors increase risk for diabetic ketoacidosis in type 2 diabetes
Griffin, Tomas P.
Dinneen, Sean F.
ANNALS OF INTERNAL MEDICINE, 2020, 173 (08) : JC40 - JC40
[30] SGLT2 Inhibitors in Type 2 Diabetes: comparatively higher Risk of Ketoacidosis
Dobler, Gabriele
DIABETOLOGIE UND STOFFWECHSEL, 2022, 17 (04) : 240 - 240

← 1 2 3 4 5 →